newsletter
SEPTEMBER 2021
About ENABLE- COST Action: A European Network to Advance Best Practices & Technology on Medication Adherence
About ENABLE- COST Action: A European Network to Advance Best Practices & Technology on Medication Adherence
The COST Action is divided into 4 main packages (WP):
Communication and Dissemination
Identifying & showcasing adherence enhancing technologies.
Job van Boven, PharmD, PhD
Dr van Boven is the Chair of the ENABLE COST Action.
Assistant Professor at University Medical Center Groningen
ENABLE-COST Action is
funded by COST; European
cooperation in Science and
technology.
One of the first milestones of the action was achieved by the launch of the WEBSITE.
In October an RT-Delphi study will be launched to gather stakeholders’ comments and views on the proposed structure for the Medication Adherence Technologies repository. The aim is to gather views from all 39 ENABLE countries and to cover five different expertise/backgrounds (education/research, clinical practice, policymaking, technologies developers and patients’ representatives).
We invite ENABLE members and partner organizations to provide contact details for potential participants in the Delphi study.
Please forward the contacts to Alex Dima (alexandra.dima@univ-lyon1.fr) or Urska Nabergoj Makovec (urska.nabergoj.makovec@ffa.uni-lj.si)
To facilitate the capacity building, and stimulate progress beyond the state-of-the-art in research and practice of medication adherence.
To discuss ENABLE COST Action progress and plan future steps.
Adaptability and Sustainability of Innovative Care Models to Improve Medication Adherence.
European Medical Device Regulation (MDR) presented by Dr. Maraina Madureira, Coordinator of the Medical Device sector at INFRAMED, Portugal.
COST provides networking opportunities for researchers and innovators in order to strengthen Europe’s capacity to address scientific, technological and societal challenges.